In this issue of Blood, Wildhagen et al demonstrate that nonanticoagulant heparin effectively blocks histone-mediated cytotoxicity and improves survival in animal models of severe infection and inflammation.1 © 2014 by The American Society of Hematology.
CITATION STYLE
Levi, M. (2014, February 13). The dual face of heparin in severe infection. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2013-12-541250
Mendeley helps you to discover research relevant for your work.